Insulin receptor-related receptor | Type II RTKs: Insulin receptor family | IUPHAR/BPS Guide to PHARMACOLOGY

Top ▲

Insulin receptor-related receptor

Target not currently curated in GtoImmuPdb

Target id: 1802

Nomenclature: Insulin receptor-related receptor

Abbreviated Name: IRR

Family: Type II RTKs: Insulin receptor family

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 1 1297 1q21-q23 INSRR insulin receptor related receptor
Mouse 1 1300 3 Insrr insulin receptor-related receptor
Rat 1 1300 2q34 Insrr insulin receptor-related receptor
Previous and Unofficial Names
IR-related receptor | Sirr
Database Links
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
RefSeq Nucleotide
RefSeq Protein
Enzyme Reaction
EC Number:

Download all structure-activity data for this target as a CSV file

Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
linsitinib Hs Inhibition 7.1 pIC50 4
pIC50 7.1 (IC50 7.5x10-8 M) [4]
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
Reference: 2,5

Key to terms and symbols Click column headers to sort
Target used in screen: INSRR
Ligand Sp. Type Action Value Parameter
NVP-TAE684 Hs Inhibitor Inhibition 8.2 pKd
GSK-1838705A Hs Inhibitor Inhibition 8.1 pKd
foretinib Hs Inhibitor Inhibition 7.3 pKd
staurosporine Hs Inhibitor Inhibition 7.1 pKd
tozasertib Hs Inhibitor Inhibition 6.5 pKd
KW-2449 Hs Inhibitor Inhibition 6.4 pKd
sunitinib Hs Inhibitor Inhibition 6.4 pKd
crizotinib Hs Inhibitor Inhibition 6.2 pKd
JNJ-28312141 Hs Inhibitor Inhibition 5.9 pKd
AST-487 Hs Inhibitor Inhibition 5.8 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

Reference: 1,3

Key to terms and symbols Click column headers to sort
Target used in screen: IRR/IRR(INSRR)
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
staurosporine Hs Inhibitor Inhibition 1.7 1.5 1.0
indirubin derivative E804 Hs Inhibitor Inhibition 2.8 2.0 2.0
SU11652 Hs Inhibitor Inhibition 4.3 13.0 0.0
SB 218078 Hs Inhibitor Inhibition 7.2 74.0 63.0
K-252a Hs Inhibitor Inhibition 14.4 6.0 1.0
GSK-3 inhibitor XIII Hs Inhibitor Inhibition 20.7 8.0 1.0
isogranulatimide Hs Inhibitor Inhibition 20.7 5.0 3.0
sunitinib Hs Inhibitor Inhibition 21.7
indirubin-3'-monoxime Hs Inhibitor Inhibition 35.7 2.0 1.0
bosutinib Hs Inhibitor Inhibition 36.9
Displaying the top 10 most potent ligands  View all ligands in screen »


Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1039-45. [PMID:22037377]

2. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

3. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem. J., 451 (2): 313-28. [PMID:23398362]

4. Mulvihill MJ, Cooke A, Rosenfeld-Franklin M, Buck E, Foreman K, Landfair D, O'Connor M, Pirritt C, Sun Y, Yao Y et al.. (2009) Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future Med Chem, 1 (6): 1153-71. [PMID:21425998]

5. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

How to cite this page

Type II RTKs: Insulin receptor family: Insulin receptor-related receptor. Last modified on 13/05/2014. Accessed on 24/09/2020. IUPHAR/BPS Guide to PHARMACOLOGY,